Abstract
We investigated the effects of thymostimulin (TST) vs placebo administration in a randomised trial performed in patients with locally advanced non-small-cell lung cancer treated with a combined modality programme that included hyperfractionated split-course thoracic radiation therapy plus chemotherapy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
